Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Common Technical Document

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 19

COMMON TECHNICAL DOCUMENT

1 / 19
ORIGIN OF CTD…

ICH
EWG

WAS OFFICIALLY SIGNED

OFF IN NOVEMBER 2000,

AT 5TH ICH CONFERENCE;


CTD
CTD
SAN DIEGO,CALIFORNIA.

2 / 19
CTD
CTD
CTD IS A JOINT EFFORT OF 3 REGULATORY AGENCIES:

1.European Medicines Agency (EMEA, Europe),

2. Food and Drug Administration (FDA, USA) and

3. Ministry of Health, Labour and Welfare


(MHLW,Japan).

CTD is maintained by ICH through EWG.

It has been adopted by several other countries


including Canada and Switzerland.

3 / 19
 Any guideline which is given by ICH passes through different steps.
 These different steps are called STATUS of that GUIDELINE.

Status of CTD
STATUS FUNCTIONALITY
STEP 4 STATUS ACHIEVED IN
Step 1 Development of Consensus NOV.2000 IN 5TH ICH
CONFERENCE IN SANDIEGO..
Step 2 Text released for consultation
STEP 5 STATUS ACHIEVED IN
Step 3 Consultation outside ICH MAY.2001 IN ICH MEETING IN
TOKYO.
Step 4 ICH guideline finalized
GUIDANCE MADE AVAILABLE
Step 5 Implementation TO INDUSTRY IN OCTOBER
16,2001 BY FDA.

4 / 19
SIGNIFICANCE OF CTD:
Avoid generating and compiling different registration dossiers

Common format will significantly reduce the time and resources

Facilitates simultaneous submission in three regions

Facilitates exchange of information among regulatory authorities

Faster availability of new medicines.

5 / 19
STRUCTURE OF CTD:

- Divided into various modules having


different contents.

6 / 19
NOT A PART OF
CTD
MODULE 1
1.REGIONAL INFO.
1.1 ToC

2.1 CTD ToC

2.2 CTD INTRODUCTION PARTS OF CTD


MODULE 2
2.4 NCO Max. 30
Max. 30 pgs. 2.5CO
2.3
QOS 2.6 NCWTS 2.7 CWTS
100 - 150 pgs. 50 - 400 pgs.
Max.40 or 80 pgs.

MODULE 3 MODULE 4 MODULE 5

3 Quality 4 non clinical study reports 5 clinical study reports


3.1 ToC 4.1 ToC 5.1 ToC

7 / 19
Paper CTD eCTD

c 1
Do
c 2 File 1 File 2
Do
c 3
Do
c 4
Do
File 3 File 4

8 / 19
eCTD:electronic CTD
- Developed by M2 EWG (Multidisciplinary 2 Expert
Working Group) of ICH.

Industry <-----> Message <------> Agency

Paper submission
has been replaced
by electronic
submission

9 / 19
Characteristics of eCTD:-

1. Files Referenced in the XML Backbone(s)


(Extensible Markup Language)

REASONS:

1.It manages the large data for the entire submission


and for each document within the submission.

2.This XML backbone allows the eCTD submission to be


viewed via a web browser and can be loaded on a Web
server.
10 / 19
2.The file formats that can be included
in the eCTD are Portable Document
Format (PDF) and XML.

However other formats can be used for


graphs and images.
JPEG
PNG
GIF
-may be used for higher resolution.

11 / 19
3. All eCTD Submissions Include Module 1

Module 1 Identifies following important information:


 Company Name
 Drug Name
 Submission Type
 Submission Date
 Application Number
 Sequence Number

12 / 19
Nomenclature for files and eCTD
submission.
EXAMPLE:- MODULE 2 FILE NOMENCLATURE AND eCTD submission

Description File Name


2.2 introduction 22-intro
2.3 Quality overall summary 23-qos
2.4 Non clinical Overview 24-nonclin-over
2.5 Clinical Overview 25-clin-over
2.6 Non clinical Written and 26-nonclin-sum
Tabulated Summaries
2.7 Clinical summary 27-clin-sum

13 / 19
Agency Sites with eCTD
submission Information
FDA : http://www.fda.gov/cder/regulatory/ersr/ectd.htm

EMEA(EU) : http://esubmission.eudra.org/

MHLW(JP) : http://www.mhlw.go.jp/english/index.html

14 / 19
Summary
CTD was introduced with the aim to harmonize
submission of technical data for registration of human
use in different regions.

After 5 years of implementation of ctd,we can say that


considerable harmonization has been achieved in
various regions for submission of technical data.

More and more regulatory agencies have started


association with this implementation generated actually
by ICH before 5 years back.
15 / 19
FOR EXAMPLE :
TGA (AUSTRALIAN REGULATORY AGENCY) has started
submission of technical data in the form of CTD.

http://www.tga.gov.au/docs/html/eugctd.htm
http://www.tga.gov.au/docs/pdf/euguide/tgamod1.pdf
http://www.tga.gov.au/docs/pdf/euguide/ich/ctdm2quality.pdf
http://www.tga.gov.au/docs/pdf/euguide/ich/ctdm2safety.pdf
http://www.tga.gov.au/docs/pdf/euguide/ich/ctdm2efficacy.pdf

AND TGA IS NOW WORKING ON A PROJECT TO IMPLEMENT eCTD for


marketing authorization, NDA, ANDA AND DIFFERENT DOSSIER
SUBMISSION.

16 / 19
Study questions:
1. What is CTD?
What are the advantages of it?
(uni. exam…2005)

2. COMMENT ON:‘CTD is a common guideline for


WHO,ICH,MCA,EMEA & USFDA.’
(uni.exam…2006)

3. What is CTD?
Why it is introduced? Who regulates it?
Give diagrammatic representation, advantages and
exclusions of it. (uni. exam…2007)

17 / 19
REFERENCES:-
www.ich.org
http://www.fda.gov/cder/regulatory/ersr/ectd.htm
http://esubmission.eudra.org/
http://www.mhlw.go.jp/english/index.html
http://www.tga.gov.au/docs/html/eugctd.htm

18 / 19
19

You might also like